James Verbsky

Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients

Use of Genetic Testing for Primary Immunodeficiency Patients

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection

IRAK4 Deficiency in a Patient with Recurrent Pneumococcal Infections: Case Report and Review of the Literature

Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic

A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease

Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology